Align Technology Stock
Align Technology, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Joseph Hogan
- Employees
- 20,435
- Market cap
- $10.5 B
- IPO
- 30/01/2001
Align Technology, Inc. is a medical technology enterprise operating in the healthcare sector and headquartered in Tempe, USA. Founded in 1997, the company develops, produces, and markets transparent dental aligners, digital intraoral scanners, and related services. The business operations are divided into two main…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Align Technology stock: price history
1D
-1.4%
1W
+3.2%
1M
-2.1%
6M
-22.5%
YTD
-5.7%
1Y
+13.5%
2Y
-31.8%
5Y
-75.0%
10Y
+62.1%
Next earnings date
Next earnings date
28/10/2026 (in 11 days)
Volatility around earnings
~100% stronger price swings than usual
Ask the agents about Align Technology
Analyst assessment of Align Technology
PRICE TARGET LOW
US$162.00
CONSENSUS
US$196.14
MEDIAN
US$189.00
PRICE TARGET HIGH
US$235.00
0
STRONG BUY
22
BUY
9
HOLD
2
SELL
0
STRONG SELL
33
TOTAL · Buy
As of: 15/10/2026
Align Technology stock metrics
P/E
25.57
P/B
2.49
EV/EBITDA
12.06
RETURN ON EQUITY
2.6%
NET MARGIN
10.3%
DEBT/EQUITY
0.03
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
94.1%
FLOAT SHARES
66,844,238
AVG. DAILY VOLUME (30D)
953,558
Insider transactions (SEC)
MORROW GEORGE J
Conroy Kevin T
LACOB JOSEPH
Dallas Kevin J
LARKIN C RAYMOND JR
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.4%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about Align Technology stock
What does Align Technology do?
Align Technology, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Joseph Hogan, the company employs around 20,435 people.
The IPO was on 30/01/2001; the stock trades on NASDAQ under the ticker ALGN.
What do analysts say about Align Technology stock?
33 analysts rate the stock, the consensus is Buy (as of 15/10/2026).
The average price target is US$196.14, ranging from US$162.00 to US$235.00, with a median of US$189.00.
This is an external assessment, not a statement by Market Jury.
When does Align Technology report next?
The next earnings date is 28/10/2026.
Around past earnings, price swings were roughly 100% stronger than usual.
Does Align Technology pay a dividend?
No, Align Technology currently does not pay a dividend.
Which stocks are comparable to Align Technology?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Bio-Rad Laboratories.
How can I get Align Technology stock analyzed?
Clicking "Analyze stock" lets five strategies assess Align Technology against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.